{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:06:00Z","timestamp":1791324360816,"version":"4.3.1"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/bjd.15947","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T17:29:37Z","timestamp":1512149377000},"page":"1143-1144","source":"Crossref","is-referenced-by-count":15,"title":["Rituximab and short\u2010course prednisone as the new gold standard for new\u2010onset pemphigus vulgaris and pemphigus foliaceus"],"prefix":"10.1093","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"D.F.","family":"Murrell","sequence":"first","affiliation":[{"name":"Department of Dermatology St George Hospital University of New South Wales Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sprecher","sequence":"additional","affiliation":[{"name":"Tel Aviv Medical Centre Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30070-3"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012"},{"key":"e_1_2_3_4_1","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin LK","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_3_5_1","unstructured":"FDA News.FDA grants breakthrough therapy designation for rituxan in pemphigus vulgaris. Available at:http:\/\/www.fdanews.com\/articles\/181113-fda-grants-breakthrough-therapy-designation-for-rituxan-in-pemphigus-vulgaris(last accessed 29 August 2017)."},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067752"},{"key":"e_1_2_3_8_1","first-page":"1008","article-title":"The next generation of targeted molecules for the treatment of chronic lymphocytic leukemia","volume":"30","author":"Jeyakumar D","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.02.555"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12615"},{"key":"e_1_2_3_11_1","unstructured":"ClinicalTrials.gov.Efficacy and safety of ofatumumab in treatment of pemphigus vulgaris. Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01920477(last accessed 29 August 2017)."},{"key":"e_1_2_3_12_1","unstructured":"ClinicalTrials.gov.Long\u2010term extension study of ofatumumab in subjects with pemphigus vulgaris. Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02613910(last accessed 29 August 2017)."},{"key":"e_1_2_3_13_1","unstructured":"ClinicalTrials.gov.Study of efficacy and safety of VAY736 in patients with pemphigus vulgaris. Available at:https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01930175(last accessed 29 August 2017)."},{"key":"e_1_2_3_14_1","unstructured":"Fierce Biotech.TaylorNP.Novartis stops PhIII trial of Genmab's arzerra after buying rights from GSK. Available at:http:\/\/www.fiercebiotech.com\/financials\/novartis-stops-phiii-trial-of-genmab-s-arzerra-after-buying-rights-from-gsk(last accessed 29 August 2017)."}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15947","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15947","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.15947","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:29:34Z","timestamp":1676384974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/177\/5\/1143\/6749711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,11]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1111\/bjd.15947"],"URL":"https:\/\/doi.org\/10.1111\/bjd.15947","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}